dc.contributor.author
Dlouhy, Ivan
dc.contributor.author
Armengol, Marc
dc.contributor.author
Recasens Zorzo, Clara
dc.contributor.author
Ribeiro, Marcelo L.
dc.contributor.author
Pérez Galán, Patricia
dc.contributor.author
Bosch, Francesc
dc.contributor.author
López Guillermo, Armando
dc.contributor.author
Roue, Gaël
dc.date.issued
2024-02-19T17:13:37Z
dc.date.issued
2024-02-19T17:13:37Z
dc.date.issued
2023-07-04
dc.date.issued
2023-07-04T10:15:28Z
dc.identifier
https://hdl.handle.net/2445/207746
dc.format
application/pdf
dc.format
application/pdf
dc.publisher
Ferrata Storti Foundation
dc.relation
Reproducció del document publicat a: https://doi.org/10.3324/haematol.2022.281988
dc.relation
Haematologica, 2022, 107, 12, 2990-2990
dc.relation
https://doi.org/10.3324/haematol.2022.281988
dc.rights
cc by-nc (c) Dlouhy, I. et al., 2022
dc.rights
http://creativecommons.org/licenses/by-nc/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
dc.subject
Mutació (Biologia)
dc.subject
Mutation (Biology)
dc.title
Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with <i>MYD88</i> L265P mutation
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
